| 87.09 Data as of Jun 06 |  +3.69 / +4.42%Today’s Change | 33.82 Today|||52-Week Range 95.85 | +50.73% Year-to-Date |
| ASCO '13 Live Blog: Prepping for Monday Trading Jun 03 / TheStreet.com | Pharmacyclics Incorporated (PCYC): Today's Featured Drugs Winner May 31 / TheStreet.com |
| Previous close | 83.40 |
| Today’s open | 83.19 |
| Day’s range | -- - -- |
| Volume | 816,587 |
| Average volume (3 months) | 800,098 |
| Market cap | $6.1B |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +69.10% |
| Revenue growth (last year) | +895.87% |
| P/E ratio | 512.3 |
| Price/Sales | 45.78 |
| Price/Book | 43.76 |
| Today’s change | Today’s % change | |
|---|---|---|
| RDYDr.Reddy's Laborator... | +0.63 | +1.69% |
| ONXXOnyx Pharmaceuticals... | +3.09 | +3.52% |
| HSPHospira Inc | +0.54 | +1.57% |
| ELNElan Corporation PLC | +0.03 | +0.24% |
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $82.0M |
| Annual profit (last year) | $12.0M |
| Net profit margin | 14.62% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert W. Duggan |
Chief Operating Officer Mahkam Zanganeh, MD, MBA |
Corporate headquarters Sunnyvale, California |
.
